Affymetrix of Santa Clara, Calif., said it has signed a licensing agreement with MWG-Biotech of Ebersberg, Germany, granting the German company the rights to certain Affymetrix intellectual property for commercializing low and medium density DNA arrays.
Under the terms of the license, MWG-Biotech has a non-exclusive, worldwide, royalty-bearing license that allows them to manufacture, use and sell low and medium density pre-spotted arrays.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.